» Articles » PMID: 34170121

Spherical Nucleic Acids for Near-Infrared Light-Responsive Self-Delivery of Small-Interfering RNA and Antisense Oligonucleotide

Overview
Journal ACS Nano
Specialty Biotechnology
Date 2021 Jun 25
PMID 34170121
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Herein, we developed a photolabile spherical nucleic acid (PSNA) for carrier-free and near-infrared (NIR) photocontrolled self-delivery of small-interfering RNA (siRNA) and antisense oligonucleotide (ASO). PSNA comprised a hydrophilic siRNA shell with a hydrophobic core containing a peptide nucleic acid-based ASO (pASO) and NIR photosensitizer (PS). The incorporation of a singlet oxygen (O)-cleavable linker between the siRNA and pASO allowed on-demand disassembly of PSNA in tumor cells once O was produced by the inner PS upon NIR light irradiation. The generated O could also concurrently promote lysosomal escape of the released siRNA and pASO to reach cytosolic targets. Both and results demonstrated that, under NIR light irradiation, PSNA could suppress hypoxia inducible factor-1α (HIF-1α) and B-cell lymphoma 2 (Bcl-2) for gene therapy (GT), which further combined photodynamic therapy (PDT) favored by the released PS to inhibit tumor cell growth. Given its carrier-free, NIR-sensitive, designable, and biocompatible merits, PSNA represents a promising self-delivery nanoplatform for cancer therapy.

Citing Articles

Navigating the intricate in-vivo journey of lipid nanoparticles tailored for the targeted delivery of RNA therapeutics: a quality-by-design approach.

Haghighi E, Abolmaali S, Dehshahri A, Mousavi Shaegh S, Azarpira N, Tamaddon A J Nanobiotechnology. 2024; 22(1):710.

PMID: 39543630 PMC: 11566655. DOI: 10.1186/s12951-024-02972-w.


Imaging-Assisted Antisense Oligonucleotide Delivery for Tumor-Targeted Gene Therapy.

Liao H, Wang S, Wang X, Dai D, Zhang Y, Zhu C Chem Biomed Imaging. 2024; 2(5):313-330.

PMID: 39474120 PMC: 11503958. DOI: 10.1021/cbmi.4c00012.


Light-Promoted Lysosomal Escape of a Phthalocyanine and Antisense Oligonucleotide-Complexed G-Quadruplex for Dual Photodynamic and Antisense Therapy.

Tam D, Lau W, Limanto Y, K P Ng D ACS Pharmacol Transl Sci. 2024; 7(10):3216-3227.

PMID: 39416965 PMC: 11475320. DOI: 10.1021/acsptsci.4c00384.


A toolbox for enzymatic modification of nucleic acids with photosensitizers for photodynamic therapy.

Niogret G, Cheriaux C, Bonhomme F, Levi-Acobas F, Figliola C, Ulrich G RSC Chem Biol. 2024; 5(9):841-852.

PMID: 39211468 PMC: 11353023. DOI: 10.1039/d4cb00103f.


Stimulus-Responsive Nanodelivery and Release Systems for Cancer Gene Therapy: Efficacy Improvement Strategies.

Zeng H, Zhang Y, Liu N, Wei Q, Yang F, Li J Int J Nanomedicine. 2024; 19:7099-7121.

PMID: 39045344 PMC: 11265383. DOI: 10.2147/IJN.S470637.